TLDR Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.
The study conducted on 303 women with Polycystic Ovary Syndrome (PCOS) found that Hispanic women had a significantly higher prevalence of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH). The study found that 83% of Hispanic women had hepatic steatosis, compared to 24% of non-Hispanics. Hispanic ethnicity was associated with two-fold higher odds of NASH, and this association persisted even after adjusting for insulin resistance and waist circumference. The study concluded that Hispanic women with PCOS are a high-risk group for NAFLD/NASH and may benefit from routine screening.
28 citations,
April 2013 in “Fertility and Sterility” Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.
4025 citations,
December 2003 in “Human Reproduction” The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.
Early detection and comprehensive treatment of PCOS are crucial due to its long-term health impacts and associated risks.
114 citations,
March 2018 in “PLOS Medicine” Women with PCOS are more than twice as likely to develop nonalcoholic fatty liver disease.
14 citations,
August 2019 in “BioMed Research International” Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.
45 citations,
January 2013 in “Journal of Human Reproductive Sciences” Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.
August 2015 in “Postgraduate obstetrics & gynecology” Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.
